Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro

European Radiology

Volumn 14, Issue 10, 2004, Pages 1851-1858

  Metz, Stephan ^a   Bonaterra, Gabriel ^b   Rudelius, Martina ^a   Settles, Marcus ^a   Rummeny, Ernst J ^a   Daldrup Link, Heike E ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cell labeling; Iron oxides; Monocytes; MR imaging; Nanoparticles

Indexed keywords

CONTRAST MEDIUM; FERUCARBOTRAN; FERUMOXTRAN 10; IRON; IRON OXIDE; RESOVIST S; SHU 555; SHU 555C; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

APOPTOSIS; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL LABELING; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; IRON TRANSPORT; MONOCYTE; NUCLEAR MAGNETIC RESONANCE; PHAGOCYTOSIS; PRIORITY JOURNAL; STAINING; STATISTICAL ANALYSIS;

APOPTOSIS; CELL SURVIVAL; COLORING AGENTS; CONTRAST MEDIA; FERRIC COMPOUNDS; FERROSOFERRIC OXIDE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MONOCYTES; OXIDES; PARTICLE SIZE; PHAGOCYTOSIS; SPECTROPHOTOMETRY, ATOMIC; TIME FACTORS;

EID: 6344253331     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2405-2     Document Type: Article

References (25)

1. Anzai Y, Blackwell KE, Hirschowitz SL, Rogers JW, Sato Y, Yuh WT, Runge VM, Morris MR, McLachlan SJ, Lufkin RB (1994) Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192:709-715
2. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM (2002) Iron-oxide-enhanced MR imaging of bone marrow with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 12:1557-1566
3. Gellissen J, Axmann Ch, Prescher A, Bohndorf K, Lodemann KP (1999) Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging. Magn Reson Imaging 17:557-567
4. Dousset V, Gomez C, Petry KG, Delalande C, Caille JM (1999) Dose and scanning delay using USPIO for central nervous system macrophage imaging. MAGMA 8:185-189
5. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103:415-422
6. Bulte JW, Ma LD, Magn RL, Kamman RL, Hulstaert CE, Go KG, The TH, de Leij L (1993) Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 29:32-37
7. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 7:258-263
8. Sipe JC, Filippi M, Martino G, Furlan R, Rocca MA, Rovaris M, Bergami A, Zyroff J, Scotti G, Comi G (1999) Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging 17:1521-1523
9. Foster-Gareau P, Heyn C, Alejski A, Rutt BK (2003) Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 49:968-971
10. Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11:2319-2331
11. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele H and Josephson L (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175:489-493
12. Jung CW (1995) Surface properties of superparamagnetic iron oxide MR contrast agents: ferrumoxides, ferrumoxtran, ferrumoxisil. Magn Res Imag 13:675-691
13. Weissleder R, Stark D, Engelstad B, Bacon B, Compton C (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol 152:167-173
14. Clarke SE, Weinmann HJ, Dai E, Lucas AR, Rutt BK (2000) Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology 214:787-794
15. Reimer P, Engelhardt M, Mahler M, Tombach B (2003) Führt das Eisenbasierte Blutpool-Kontrastmittel SH U 555 C zu Signalveränderungen in den Nieren? Ergebnisse einer Plazebo-kontrollierten MRA Studie. RöFo 1(Suppl 1):237
16. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E and Frija G (1993) Superparamagnetic iron oxides as positive contrast agents: in vitro and in vivo evidence. Magn Reson imaging 11:509-519
17. McLachlan SJ, Morris MR, Lucas MA, Fisco RA, Eakins MN, Fowler DR, Scheetz RB, Olukotun AY (1994) Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 4:301-307
18. Idziorek T, Estaquier J, De-Bels F, Ameisen JC (1995) YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods 185:249-258
19. Deigner HP, Claus R, Bonaterra GA, Gehrke C, Bibak N, Blaess M, Cantz M, Metz J, Kinscherf R (2001) Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. FASEB J 15:807-814
20. Kinscherf R, Deigner HP, Usinger C, Pill J, Wagner M, Kamencic H, Hou D, Chen M, Schmiedt W, Schrader M, Kovacs G, Kato K, Metz J (1997) Induction of manganese superoxide dismutase by oxidized-LDL - its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 11:1317-1328
21. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK (2002) Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 48:52-61
22. Daldrup-Link HE, Rudelius M, Oostendorp RAJ, Settles M, Piontek G, Metz S, Heinzmann U, Rummeny EJ, Schlegel J, Link TM (2003) Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228:760-767
23. Matuszewski L, Wall A, Persigehl T, Schwindt W, Tombach B, Fobker M, Poremba C, Heindel W, Bremer C (2003) Cell tagging with superparamagnetic iron-oxide particles: impact of hydrodynamic diameter and coating on labeling efficiency. Mol Imaging 2:268
24. Brillet PY, Clément O, Bessoud B, Luciani A, Siauve N, Cuénod CA (2003) Use of two superparamagnetic iron oxide particles (SPIO) for tumoral imaging: in vitro and in vivo studies. Eur Radiol 13(Suppl 1):439
25. Fleige G, Seeberger F, Laux D, Kresse M, Taupitz M, Pilgrimm H, Zimmer C (2002) In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Invest Radiol 37:482-488